← Open Payments lookup

RICHARD TAN: Open Payments

NPI 1548936602 · ALHAMBRA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$994 in 50 payments from 12 companies in 2025. Trend: 2023 $282 · 2024 $973 · 2025 $994

Food & beverage: $994
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$290
Amgen Inc.27$280
Novo Nordisk Inc2$141
Dexcom, Inc.2$43
Otsuka America Pharmaceutical, Inc.2$42
Merck Sharp & Dohme LLC2$41
Novartis Pharmaceuticals Corporation2$39
Boehringer Ingelheim Pharmaceuticals, Inc.1$32
Aimmune Therapeutics, Inc.1$26
Lilly USA, LLC1$25

Products named: OTEZLA, AIRSUPRA, Ozempic, BREZTRI, Dexcom G6 Transmitter, REXULTI, LEQVIO, JARDIANCE.

Industry payments across CA — which companies pay providers there.